To assess aortic stiffness by transesophageal echocardiography (TEE) and to determine its clinical predictors and relation to age, blood pressure, renal function, and atherosclerosis, 50 patients with systemic lupus erythematosus (SLE), 94% women, with a mean age of 38 AE 12 years, and 22 age and gender-matched healthy controls underwent clinical and laboratory evaluations and multiplane TEE to assess stiffness, intima-media thickness (IMT), and plaques of the proximal, mid, and distal descending thoracic aorta. Stiffness at each level and overall aortic stiffness by the pressure-strain elastic modulus was higher in patients than in controls after adjusting for age (overall, 8.25 AE 4.13 versus 6.1 AE 2.5 Pascal units, p ¼ 0.01). Patients had higher aortic stiffness than controls after adjusting both groups to the same mean age, blood pressure, creatinine, and aortic IMT (p ¼ 0.005). Neither IMT nor plaques were predictors of aortic stiffness. Moreover, normotensive patients, those without aortic plaques, and non-smokers had higher stiffness than controls (all p < 0.05). Age at SLE diagnosis and non-neurologic damage score were the only SLE-specific independent predictors of aortic stiffness (both p 0.01). Thus, increased aortic stiffness is an early manifestation of lupus vasculopathy that seems to precede the development of hypertension and atherosclerosis. Lupus (2010) 19, 1599-1605.
Introduction
Patients with systemic lupus erythematosus (SLE) have a high prevalence of hypertension and premature coronary and carotid atherosclerosis that substantially increases their morbidity and mortality. [1] [2] [3] [4] [5] [6] [7] Patients with SLE also develop arterial stiffness, but it is uncertain if arterial stiffness occurs independently of age, hypertension, renal function, or atherosclerosis. 8, 9 In addition, aortic stiffness may be causally related to the development of hypertension and premature aortic atherosclerosis. 10 Therefore, this study was designed with three objectives: (1) to directly assess aortic stiffness using transesophageal echocardiography (TEE) in young SLE patients as compared with age and gender-matched healthy controls; (2) to determine the clinical predictors of aortic stiffness; and (3) to determine if aortic stiffness occurs independently of age, blood pressure, renal function, and aortic atherosclerosis.
Patients and methods

Study populations
Fifty consecutive patients with a diagnosis of SLE according to criteria by the ACR, 46 women, with a mean age of 38 AE 12 years (range, 18-60) and 22 healthy volunteers, 19 women, with a mean age of 34 AE 12 years (range, 18-57) agreed to participate in the study. Patients with SLE were recruited from a well-characterized population of about 200 patients aged between 18 and 60 years, regularly followed at the Rheumatology Clinics of the University of New Mexico Health Sciences Center. This study protocol was approved by the Institutional Review Board and all participating subjects signed an approved informed consent.
Clinical and laboratory evaluations
Patients and controls underwent clinical and laboratory evaluations including specific parameters of inflammation (Table 1) . Also, SLE patients were further characterized with regard to their disease duration, activity, severity, therapy, and serology including antiphospholipid antibodies (Table 2) .
Transesophageal echocardiography
All subjects underwent multiplane TEE with Philips I-E33 imaging systems using a 7 MHz transducer with an axial resolution of approximately 0.1 mm. At a low depth (3-4 cm) and using a narrow sector scan to improve image resolution, two-dimensional guided M-mode images were used to assess aortic systolic and diastolic diameters and intima-media thickness (IMT) of the aortic anterior wall at the proximal (25-30 cm from the incisors), mid (30-35 cm) and distal descending thoracic aorta (35-40 cm). Aortic diameters were measured from the short and long-axis views during end-systole and end-diastole (peak to end of T wave and after P wave on the electrocardiogram, respectively) (Figure 1) . At each aortic level, 3-6 measurements of diameters and IMT were averaged. Far-field decreased resolution and common off-axis views precluded accurate assessment of diameters and IMT of ascending aorta and arch. All studies were codified, digitally stored, and those of patients and controls were randomly intermixed. Also, all studies were interpreted and measured off line using electronic calipers by experienced observers blinded to all subjects' clinical data. To further avoid interpretation bias, one observer (JJ) assessed aortic diameters and a second observer (CAR) assessed IMT and plaques. Finally, to assess intra-observer reliability, 26 randomly selected studies (from 16 patients and 10 controls) had repeated measurements of aortic diameters.
Blood pressures
During TEE and at each aortic level, multiple blood pressure measurements were obtained from the brachial artery using an automatic Dash 2000 sphygmomanometer. Blood pressures were matched in time with aortic measurements.
Assessment of aortic stiffness and atherosclerosis
Aortic stiffness was assessed with the Pressure-
, where k ¼ 133.3 is a conversion factor from mmHg to Pascal units, sBP is systolic blood pressure, dBP is diastolic blood pressure, sD is systolic diameter, and dD is diastolic diameter.
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PSEM is a well-established and validated parameter of arterial stiffness that defines the amount of force (pulse pressure) required to distend a vessel. This parameter allows assessment of aortic stiffness independently of IMT or plaques. Atherosclerosis was defined as aortic plaques manifested as >50%
focal or protruding wall thickening as compared with surrounding walls.
4,5,12
Statistical analysis
Student's t-test or Wilcoxon rank-sum test (for normally or non-normally distributed data) and Fisher's exact test were used for comparison of continuous and categorical variables among groups, respectively. Analysis of aortic stiffness was performed with repeated measures analysis of variance (ANOVA) where the three aortic locations of measurements constitute a repeated factor and SLE patients versus control subjects constitute the group factor. The 'best' multivariate models were obtained by stepwise regression and verified by 'all subsets' regression for the stiffness parameter on the candidate predictors (those with p < 0.05 in univariate analysis). The effect size for a predictor in both univariate and multivariate models are reported as correlations or standardized betas (regression coefficients of the standardized outcome and predictor variables). To further determine that aortic stiffness in patients with SLE occurs independently of age, blood pressure, renal function, and atherosclerosis, we adjusted by multivariate Figure 1 Measurement of aortic diameters and intima-media thickness. This transesophageal echocardiography short-axis twodimensional guided M-mode image of the proximal descending thoracic aorta in a patient with SLE demonstrates the measurements of the aortic systolic diameter (sD) at the peak of the T wave on the electrocardiogram and measurement of the diastolic diameter (dD) and aortic intima-media thickness (IMT) during end-diastole (after the P wave on the electrocardiogram).
The systolic and diastolic diameters and IMT measured 1.8 cm, 1.6 cm, and 0.6 mm, respectively.
regression each individual's PSEM at each aortic location to the same mean age (37 years old), arterial blood pressure (86 mmHg), creatinine (0.80 mg/dl), and IMT (0.81 mm). These means are for the pooled data of patients and controls. A twotailed p-value < 0.05 was considered significant.
Results
Clinical characteristics of patients and controls
Patients with SLE and controls were similar in age, gender, and body mass index. However, SLE patients had higher ambulatory blood pressures, more atherogenic risk factors, higher creatinine (only three patients had values >1 mg/dl) and lower hematocrit, platelets, and albumin than controls (all p 0.04, Table 1 ). Clinical, therapy, and laboratory data specific to SLE patients are delineated in Table 2 .
Blood pressures, aortic diameters, aortic intimamedia thickness and plaques in patients and controls versus 0%, respectively, both p 0.02). The percent error in the measurement of systolic and diastolic diameters at the proximal, mid, and distal aorta were 6% and 6%, 2% and 3%, and 4% and 6%, respectively.
Aortic stiffness in patients and controls
Stiffness was higher in all SLE patients, in all normotensive SLE patients (sBP 135 and dBP 85 mmHg), in normotensive SLE patients on no antihypertensive therapy, in those without aortic plaques, and in non-smokers as compared with controls (all p < 0.05) (Table 3) . Also, aortic stiffness was higher in patients with than without pre or hypertension during TEE, but not in those (Figure 2 ). In addition, after adjustment of both groups to the same mean age, arterial blood pressure, creatinine, and IMT, patients with SLE still had significantly higher aortic stiffness as compared with controls (p ¼ 0.005), with a linear trend upwards of stiffness from proximal to distal aorta (p ¼ 0.04) (Figure 3 ).
Predictors of aortic stiffness in patients with SLE
By univariate analyses including all clinical, therapy, and laboratory variables listed in Tables 1 and  2 , age of SLE diagnosis, mean arterial blood pressure during TEE, non-neurologic and total SLE damage scores, C3a, IgG anticardiolipin antibodies, total cholesterol and platelets levels were predictors of aortic stiffness (all p 0.05). However, aortic IMT, aortic plaques, smoking, and any atherogenic risk factor, were not predictors. By multivariate analyses, age of SLE diagnosis, nonneurologic SLE damage score, and mean arterial blood pressure during TEE (as expected, since blood pressure is a factor in the calculation of stiffness) were the only independent predictors of aortic stiffness (all p < 0.02) ( Table 4) .
Discussion
Major findings
There are two major findings in this study:
(1) aortic stiffness is higher in young SLE patients as compared with matched controls, and remained so after simultaneously adjusting both groups to the same age, renal function, blood pressure, and aortic atherosclerosis; and (2) in patients with SLE, age of SLE diagnosis and non-neurologic damage score are the only SLE-specific independent predictors of aortic stiffness. To our knowledge this is the first TEE series in young SLE patients to directly demonstrate the occurrence of aortic stiffness independently of age, blood pressure, renal function, and early aortic atherosclerosis. This study findings suggest that the later in life SLE is diagnosed, the higher the likelihood that untreated immune-mediated vascular inflammation or damage leads to aortic stiffness. However, since the age of SLE diagnosis is known but the age of SLE onset is not, it is also possible that the later the age at SLE diagnosis, the higher the likelihood that age-related aortic stiffness occurs.
In this study, all normotensive SLE patients as well as normotensive SLE patients on no antihypertensive therapy had higher aortic stiffness than controls. Also, aortic stiffness was higher in patients with than without hypertension. These findings support that once SLE related aortic stiffness occurs, hypertension may follow and result in a perpetuating vicious cycle of progressive large vessel vasculopathy. 3, 8, 9, [10] [11] [12] [13] [14] [15] However, SLE-related hypertension may also lead to aortic stiffness, which then also perpetuates hypertension. In this study, SLE patients had a higher range of nonhypertensive blood pressures than controls, 14% of patients had hypertension and 28% were either hypertensive or on vasodilator therapy. This is a significantly higher prevalence of hypertension in young SLE women as compared with that of a similar age and gender general population ($5%). 16 Also, hypertension was not related to the low prevalence of renal disease (6%) and postmenopausal status (15%), nor to body mass index since patients and controls had similar values. Similarly high prevalence rates (29-36%) of hypertension have been reported in several series of premenopausal SLE women. 2, 3, 15, 17 Therefore, the putative mechanisms of hypertension in SLE, such as inflammatory cytokine-mediated endothelial dysfunction, hyperactivity of the renin-angiotensin system resulting in increased production of angiotensin II and endothelin-1 (both potent vasoconstrictors), increased oxidative stress, steroid therapy, and insulin resistance may all actually contribute to aortic stiffness and then to hypertension, or both simultaneously. 2, 14, 18 In addition, in this study patients with SLE without aortic plaques had higher aortic stiffness than controls. Although not statistically significant, aortic stiffness was also higher in patients with than without aortic plaques. These findings also support that aortic stiffness in SLE may be an important pathogenic or exacerbating factor for aortic atherosclerosis, which then sets up a selfperpetuating pathologic cycle. 10, [13] [14] [15] In this study, 28% of patients had aortic plaques (p ¼ 0.004 versus controls), a similar prevalence to that of coronary (31%) and carotid (37%) atherosclerosis reported in other series. 4, 15, 19 Therefore, aortic stiffness in SLE may lead or contribute to the development of hypertension, which begets stiffness and both may accelerate aortic atherosclerosis.
Comparison with previous studies
Although no previous series have directly assessed aortic stiffness by TEE in SLE, several series using arterial tonometry have demonstrated either aortic or peripheral arterial stiffness manifested by an increased carotid-to-femoral pulse wave velocity (PWV). 5, 8, 9 Selzer et al. in a non-controlled study of 214 SLE women without clinical cardiovascular disease with a mean age of 45.2 AE 10.5 years (included patients > 60 years old), demonstrated that aortic stiffness by PWV was associated with older age, higher systolic blood pressure, higher C3 levels, lower white blood cell count, higher insulin levels, and renal disease. 3 Bjarnegra˚d et al., in 27 women with SLE (52-68 years old) and 27 controls, demonstrated that carotid-to-femoral PWV was higher in women with SLE than in controls after correction for mean arterial pressure and body mass index. 8 Also, aortic PWV was positively associated to C-reactive protein and complement factor 3. Finally, Yildiz et al. demonstrated higher carotid-femoral PWV in 24 premenopausal SLE women as compared with 24 age and sex-matched controls. 9 Aortic stiffness was correlated with age, body mass index, waist-to-hip ratio, heart rate and blood pressure. Unlike our study, these series did not demonstrate the occurrence of aortic stiffness independently of age, blood pressure, renal function, and aortic atherosclerosis.
Limitations of the study
An underestimation of aortic stiffness may have occurred because this study population only represents about 25% of patients regularly followed at our institution; thus, patients with severe disease may be underrepresented. The proportion of patients with renal dysfunction studied (6%) was low, and the assessment of IMT and plaques of the aortic posterior wall was limited, and therefore aortic atherosclerosis may have been underestimated. In contrast, the small healthy control group may have led to an overestimation of the independent effect of SLE on aortic stiffness. Also, an independent effect of blood pressure on aortic stiffness could only be partially ascertained because assessment of aortic stiffness includes blood pressure as a factor. However, when patients' and controls' mean arterial blood pressure was adjusted to the same normal value, or normotensive patients on or on no antihypertensive therapy were compared with controls, aortic stiffness was still significantly higher in patients than in controls. Finally, although the specific effect of different SLE therapies on aortic stiffness was not assessed, they were not predictors in the univariate and multivariate analyses.
Clinical implications
This study may have several clinical implications: (1) increased aortic stiffness is an early manifestation of lupus vasculopathy that seems to precede the development of hypertension and atherosclerosis; 20 (2) SLE-associated chronic immune-mediated inflammation and damage to the arterial wall may cause aortic stiffness, which then may lead to or exacerbate hypertension, and then to atherosclerosis; 18 (3) earlier diagnosis and aggressive antiinflammatory therapy of SLE has the potential to prevent the development and progression of aortic stiffness, hypertension, and atherosclerosis; 18, 21 and (4) statin, angiotensin-converting enzyme inhibitor, and anti-platelet therapy may also have primary and secondary preventive effects due to the SLE-associated high prevalence of dyslipidemia, endothelial dysfunction, hypertension, vascular stiffness, and atherosclerosis. 22, 23 These interventions have the potential to decrease the prevalence and incidence of cardiac and cerebrovascular diseases in SLE and their associated high morbidity and mortality. However, a large prospective controlled cross-sectional and longitudinal study is necessary to define better the short and long-term prognosis of aortic stiffness on cardiac and cerebrovascular outcomes in SLE.
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